TY - JOUR
T1 - Peak oxygen uptake, ventilatory efficiency and QRS-duration predict event free survival in patients late after surgical repair of tetralogy of Fallot
AU - Müller, Jan
AU - Hager, Alfred
AU - Diller, Gerhard Paul
AU - Derrick, Graham
AU - Buys, Roselien
AU - Dubowy, Karl Otto
AU - Takken, Tim
AU - Orwat, Stefan
AU - Inuzuka, Ryo
AU - Vanhees, Luc
AU - Gatzoulis, Michael
AU - Giardini, Alessandro
PY - 2015/7/23
Y1 - 2015/7/23
N2 - Objective Patients with repaired tetralogy of Fallot (ToF) have an increased long-term risk of cardiovascular morbidity and mortality. Risk stratification in this population is difficult. Initial evidence suggests that cardiopulmonary exercise testing (CPET) may be helpful to risk-stratify patients with repaired ToF. Methods and results We studied 875 patients after surgical repair for ToF (358 females, age 25.5 ± 11.7 year, range 7-75 years) who underwent CPET between 1999 and 2009. During a mean follow-up of 4.1 ± 2.6 years after CPET, 30 patients (3.4%) died or had sustained ventricular tachycardia (VT). 225 patients (25.7%) had other cardiac related events (emergency admission, surgery, or catheter interventions). On multivariable Cox regression-analysis, %predicted peak oxygen uptake (V O2 %) (p = 0.001), resting QRS duration (p = 0.030) and age (p < 0.001) emerged as independent predictors of mortality or sustained VT. Patients with a peak VO2 65% of predicted and a resting QRS duration 170 ms had a 11.4-fold risk of death or sustained VT. Ventilatory efficiency expressed as VE/VCO2 slope (p 0.001), peak VO2 % (p =.001), QRS duration (p =.001) and age (p = 0.046) independently predicted event free survival. VE/VCO2 slope 31.0, peak VO2 % 65% and QRS duration 170 ms were the cut-off points with best sensitivity and specificity to detect an unfavorable outcome. Conclusions CPET is an important predictive tool that may assist in the risk stratification of patients with ToF. Subjects with a poor exercise capacity in addition to a prolonged QRS duration have a substantially increased risk for death or sustained ventricular tachycardia, as well as for cardiac-related hospitalizations.
AB - Objective Patients with repaired tetralogy of Fallot (ToF) have an increased long-term risk of cardiovascular morbidity and mortality. Risk stratification in this population is difficult. Initial evidence suggests that cardiopulmonary exercise testing (CPET) may be helpful to risk-stratify patients with repaired ToF. Methods and results We studied 875 patients after surgical repair for ToF (358 females, age 25.5 ± 11.7 year, range 7-75 years) who underwent CPET between 1999 and 2009. During a mean follow-up of 4.1 ± 2.6 years after CPET, 30 patients (3.4%) died or had sustained ventricular tachycardia (VT). 225 patients (25.7%) had other cardiac related events (emergency admission, surgery, or catheter interventions). On multivariable Cox regression-analysis, %predicted peak oxygen uptake (V O2 %) (p = 0.001), resting QRS duration (p = 0.030) and age (p < 0.001) emerged as independent predictors of mortality or sustained VT. Patients with a peak VO2 65% of predicted and a resting QRS duration 170 ms had a 11.4-fold risk of death or sustained VT. Ventilatory efficiency expressed as VE/VCO2 slope (p 0.001), peak VO2 % (p =.001), QRS duration (p =.001) and age (p = 0.046) independently predicted event free survival. VE/VCO2 slope 31.0, peak VO2 % 65% and QRS duration 170 ms were the cut-off points with best sensitivity and specificity to detect an unfavorable outcome. Conclusions CPET is an important predictive tool that may assist in the risk stratification of patients with ToF. Subjects with a poor exercise capacity in addition to a prolonged QRS duration have a substantially increased risk for death or sustained ventricular tachycardia, as well as for cardiac-related hospitalizations.
KW - Event free survival
KW - Exercise testing
KW - Peak VO<inf>2</inf>
KW - QRS duration
KW - Tetralogy of Fallot
KW - Ventilatory efficiency
UR - http://www.scopus.com/inward/record.url?scp=84937409413&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2015.05.174
DO - 10.1016/j.ijcard.2015.05.174
M3 - Article
C2 - 26114442
AN - SCOPUS:84937409413
SN - 0167-5273
VL - 196
SP - 158
EP - 164
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -